Notification of HIV status disclosure and its related factors in HIV-infected adolescents in 2009 in the Aconda program (CePReF, CHU Yopougon) in Abidjan, Côte d'Ivoire, the PRADO-CI study

Journal of the International AIDS Society

Volumn 16, Issue , 2013, Pages

  Meless, Guanga David ^a   Aka Dago Akribi, Hortense ^b   Cacou, Chantal ^b   Eboua, Tanoh François ^c   Aka, Addi Edmond ^d   Oga, Aimé Maxime ^a   Bouah, Belinda ^b   Eugène, Messou ^d   Moh, Corinne ^b   Arrivé, Elise ^e,f   Timité Konan, Marguerite ^c   Leroy, Valériane ^e,f  

^a Programme PAC CI   (Côte d’Ivoire)

^b UNIVERSITÉ FÉLIX HOUPHOUËT BOIGNY   (Côte d’Ivoire)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE YOPOUGON   (Côte d’Ivoire)

^d CePReF   (Côte d’Ivoire)

^e INSERM   (France)

^f UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Adolescents and youth; Antiretroviral treatment; Disclosure; HIV; Prevention; Sub Saharan Africa

Indexed keywords

COTRIMOXAZOLE;

ADOLESCENT; ADULT; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL RECORD; PRIORITY JOURNAL; ADOLESCENTS AND YOUTH; AGE; ANTIRETROVIRAL TREATMENT; COTE D'IVOIRE; GEOGRAPHY; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION CONTROL; PREVENTION; STATISTICS; SUB-SAHARAN AFRICA;

ADOLESCENTS AND YOUTH; ANTIRETROVIRAL TREATMENT; DISCLOSURE; HIV; PREVENTION; SUB-SAHARAN AFRICA;

ADOLESCENT; AGE FACTORS; COTE D'IVOIRE; CROSS-SECTIONAL STUDIES; DISCLOSURE; DISEASE NOTIFICATION; FEMALE; GEOGRAPHY; HIV INFECTIONS; HUMANS; MALE; YOUNG ADULT;

EID: 84887286690     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.16.1.18569     Document Type: Article

References (40)

1. UNAIDS. UNAIDS World AIDS day report 2011. How to get to zero faster, smarter, better. Geneva: UNAIDS; 2011.
2. Foster C, Waelbrouck A, Peltier A. Adolescents and HIV infection. Curr Opin HIV AIDS. 2007;2(5):431-6.
3. Foster C, Fidler S. Optimizing antiretroviral therapy in adolescents with perinatally acquired HIV-1 infection. Expert Rev Anti-Infect Ther. 2010;8(12): 1403-16.
4. UNAIDS. UNAIDS Report on the global AIDS epidemic. Geneva: UNAIDS; 2010.
5. Wilson C, Wright P, Safrit J, Rudy B. Epidemiology of HIV infection and risk in adolescents and youth. J Acquir Immune Defic Syndr. 2010;54(Suppl 1):S5-6.
6. Gray GE. Adolescent HIV-cause for concern in Southern Africa. PLoS Med. 2010;7(2):e1000227.
7. Musisi S, Kinyanda E. Emotional and behavioural disorders in HIV seropositive adolescents in urban Uganda. East Afr Med J. 2009;86(1):16-24.
8. Menon A, Glazebrook C, Campain N, Ngoma M. Mental health and disclosure of HIV status in Zambian adolescents with HIV infection: implications for peer-support programs. J Acquir Immune Defic Syndr. 2007;46(3): 349-54.
9. Ding H, Wilson CM, Modjarrad K, McGwin G, Jr., Tang J, Vermund SH. Predictors of suboptimal virologic response to highly active antiretroviral therapy among human immunodeficiency virus-infected adolescents: analyses of the reaching for excellence in adolescent care and health (REACH) project. Arch Pediatr Adolesc Med. 2009;163(12):1100-5.
10. Rudy BJ, Crowley-Nowick PA, Douglas SD. Immunology and the REACH study: HIV immunology and preliminary findings. Reaching for Excellence in Adolescent Care and Health. J Adolesc Health. 2001;29(Suppl 3):39-48.
11. Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr. 2009;51(1):65-71.
12. Gerson AC, Joyner M, Fosarelli P, Butz A, Wissow L, Lee S, et al. Disclosure of HIV diagnosis to children: when, where, why, and how. J Pediatr Health Care. 2001;15(4):161-7.
13. Haberer JE, Cook A, Walker AS, Ngambi M, Ferrier A, Mulenga V, et al. Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects. PLoS One. 2011;6(4):e18505.
14. Arrive E, Dicko F, Amghar H, Aka AE, Dior H, Bouah B, et al. HIV status disclosure and retention in care in HIV-infected adolescents on antiretroviral therapy (ART) in West Africa. PLoS One. 2012;7(3):e33690.
15. World Health Organization. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach. Revision 2010. Geneva: WHO; 2010.
16. ANECCA, [African network for the care of children affected by HIV/AIDS HoPAiA] Réseau Africain pour les soins aux enfants affectés par le SIDA. Manuel sur le SIDA pédiatrique en Afrique Edition Révisée, Juillet 2006. Oxford, UK: Blackwell Science; 2006.
17. World Health Organization. Guideline on HIV disclosure counselling for children up to 12 years of age. Geneva: WHO; 2011.
18. Abebe W, Teferra S. Disclosure of diagnosis by parents and caregivers to children infected with HIV: prevalence associated factors and perceived barriers in Addis Ababa, Ethiopia. AIDS Care. 2012;24(9):1097-102.
19. Arun S, Singh AK, Lodha R, Kabra SK. Disclosure of the HIV infection status in children. Indian J Pediatr. 2009;76(8):805-8.
20. Bhattacharya M, Dubey AP, Sharma M. Patterns of diagnosis disclosure and its correlates in HIV-infected North Indian children. J Trop Pediatr. 2011;57(6):405-11.
21. Biadgilign S, Deribew A, Amberbir A, Escudero HR, Deribe K. Factors associated with HIV/AIDS diagnostic disclosure to HIV infected children receiving HAART: a multi-center study in Addis Ababa, Ethiopia. PLoS One. 2011;6(3):e17572.
22. Bikaako-Kajura W, Luyirika E, Purcell DW, Downing J, Kaharuza F, Mermin J, et al. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav. 2006;10(Suppl 4):S85-93.
23. Brown BJ, Oladokun RE, Osinusi K, Ochigbo S, Adewole IF, Kanki P. Disclosure of HIV status to infected children in a Nigerian HIV Care Programme. AIDS Care. 2011;23(9):1053-8.
24. Calabrese SK, Martin S, Wolters PL, Toledo-Tamula MA, Brennan TL, Wood LV. Diagnosis disclosure, medication hiding, and medical functioning among perinatally infected, HIV-positive children and adolescents. AIDS Care. 2012; 24(9):1092-6.
25. De Baets AJ, Sifovo S, Parsons R, Pazvakavambwa IE. HIV disclosure and discussions about grief with Shona children: a comparison between health care workers and community members in Eastern Zimbabwe. Soc Sci Med. 2008;66(2):479-91.
26. Heeren GA, Jemmott JB, 3rd, Sidloyi L, Ngwane Z. Disclosure of HIV diagnosis to HIV-infected children in South Africa: focus groups for intervention development. Vulnerable Child Youth Stud. 2012;7(1):47-54.
27. Kallem S, Renner L, Ghebremichael M, Paintsil E. Prevalence and pattern of disclosure of HIV status in HIV-infected children in Ghana. AIDS Behav. 2011;15(6):1121-7.
28. Oberdorfer P, Puthanakit T, Louthrenoo O, Charnsil C, Sirisanthana V, Sirisanthana T. Disclosure of HIV/AIDS diagnosis to HIV-infected children in Thailand. J Paediatr Child Health. 2006;42(5):283-8.
29. Vaz LM, Maman S, Eng E, Barbarin OA, Tshikandu T, Behets F. Patterns of disclosure of HIV status to infected children in a Sub-Saharan African setting. J Dev Behav Pediatr. 2011. [Epub ahead of print].
30. Bakanda C, Birungi J, Mwesigwa R, Nachega J, Chan K, Palmer A, et al. Survival of HIV-infected adolescents on antiretroviral therapy in Uganda: findings from a nationally representative cohort in Uganda. PLoS One. 2011;6(4):e19261.
31. Vreeman RC, Nyandiko WM, Ayaya SO, Walumbe EG, Marrero DG, Inui TS. The perceived impact of disclosure of pediatric HIV status on pediatric antiretroviral therapy adherence, child well-being, and social relationships in a resource-limited setting. AIDS Patient Care STDS. 2010;24(10):639-49.
32. Moodley K, Myer L, Michaels D, Cotton M. Paediatric HIV disclosure in South Africa-caregivers' perspectives on discussing HIV with infected children. S Afr Med J. 2006;96(3):201-4.
33. Anaky MF, Duvignac J, Wemin L, Kouakoussui A, Karcher S, Toure S, et al. Scaling up antiretroviral therapy for HIV-infected children in Cote d'Ivoire: determinants of survival and loss to programme. Bull World Health Organ. 2010;88(7):490-9.
34. Toure S, Kouadio B, Seyler C, Traore M, Dakoury-Dogbo N, Duvignac J, et al. Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: twoyear outcomes and determinants. AIDS. 2008;22:873-82.
35. Rouet F, Ekouevi DK, Chaix ML, Burgard M, Inwoley A, Tony TD, et al. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting. J Clin Microbiol. 2005;43(6):2709-17.
36. République de Côte d'Ivoire. Guide de prise en charge pédiatrique de l'infection par le VIH en Côte d'Ivoire [Guide on pediatric care of HIV in Côte d'Ivoire]. Abidjan: Ministère de la Santé et de l'Hygiène Publique. Ministère de la Lutte contre le SIDA; 2006. 156 p.
37. World Health Organization.WHO HIV prevention and treatment guidelines. Antiretroviral therapy of HIV infection in infants and children in resourcelimited settings, towards universal access: recommendations for a public health approach (2006 version). Geneva: WHO; 2006.
38. Foster SD, Nakamanya S, Kyomuhangi R, Amurwon J, Namara G, Amuron B, et al. The experience of "medicine companions" to support adherence to antiretroviral therapy: quantitative and qualitative data from a trial population in Uganda. AIDS Care. 2010;22(Suppl 1):35-43.
39. Michaud PA, Suris JC, Thomas LR, Kahlert C, Rudin C, Cheseaux JJ. To say or not to say: a qualitative study on the disclosure of their condition by human immunodeficiency virus-positive adolescents. J Adolesc Health. 2009; 44(4):356-62.
40. Rujumba J, Mbasaalaki-Mwaka CL, Ndeezi G. Challenges faced by health workers in providing counselling services to HIV-positive children in Uganda: a descriptive study. J Int AIDS Soc. 2010;13:9.